Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
出版年份 2020 全文链接
标题
Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
作者
关键词
-
出版物
ONCOGENE
Volume 39, Issue 31, Pages 5373-5389
出版商
Springer Science and Business Media LLC
发表日期
2020-06-19
DOI
10.1038/s41388-020-1364-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Respiratory Capacity and Reserve Predict Cell Sensitivity to Mitochondria Inhibitors: Mechanism-Based Markers to Identify Metformin-Responsive Cancers
- (2019) Jing Tsong Teh et al. MOLECULAR CANCER THERAPEUTICS
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
- (2018) Steven W. Plouffe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
- (2018) Yulei Zhao et al. MOLECULAR CANCER RESEARCH
- Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
- (2018) Hisham F. Bahmad et al. Frontiers in Oncology
- OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ
- (2018) Zhengkui Zhang et al. MOLECULAR CELL
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer
- (2017) Kanjoormana Aryan Manu et al. MOLECULAR CANCER THERAPEUTICS
- Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis
- (2017) M T Do et al. ONCOGENE
- Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms
- (2017) H Y Lau et al. ONCOGENE
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Protein prenylation: unique fats make their mark on biology
- (2016) Mei Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
- (2016) Sameerah Shaheen et al. Stem Cell Reviews and Reports
- Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer
- (2016) Sameerah Shaheen et al. Stem Cell Reviews and Reports
- Eradicating tumor drug resistance at its YAP-biomechanical roots
- (2015) F. Zanconato et al. EMBO JOURNAL
- YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells
- (2015) YANLI YUAN et al. Molecular Medicine Reports
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- Oncogenic K-Ras promotes proliferation in quiescent intestinal stem cells
- (2015) Jessica J. Gierut et al. Stem Cell Research
- Activated K-Ras, but Not H-Ras or N-Ras, Regulates Brain Neural Stem Cell Proliferation in a Raf/Rb-Dependent Manner
- (2015) R. Hugh F. Bender et al. STEM CELLS
- NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
- (2015) M. E. R. Garcia-Rendueles et al. Cancer Discovery
- An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo
- (2014) Hiu Yeung Lau et al. CANCER BIOLOGY & THERAPY
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
- (2014) X. Hong et al. EMBO JOURNAL
- The Hippo signaling pathway in stem cell biology and cancer
- (2014) J.-S. Mo et al. EMBO REPORTS
- Erratum
- (2014) JNCI-Journal of the National Cancer Institute
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism
- (2014) J T Teh et al. ONCOGENE
- TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
- (2014) M Bartucci et al. ONCOGENE
- Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
- (2014) W. Zhang et al. Science Signaling
- Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer
- (2013) N. Awasthi et al. CARCINOGENESIS
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins
- (2013) B.V.V.G. Reddy et al. DEVELOPMENTAL CELL
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
- (2012) Anke Van den broeck et al. BMC CANCER
- The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition
- (2012) Wei Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway
- (2011) Carole L.C. Poon et al. DEVELOPMENTAL CELL
- Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway
- (2011) Julian C. Boggiano et al. DEVELOPMENTAL CELL
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
- (2011) K. P. L. Bhat et al. GENES & DEVELOPMENT
- A Role for Rac3 GTPase in the Regulation of Autophagy
- (2011) Wan Long Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAZ is a novel oncogene in non-small cell lung cancer
- (2011) Z Zhou et al. ONCOGENE
- Multicellular tumor spheroids: An underestimated tool is catching up again
- (2010) Franziska Hirschhaeuser et al. JOURNAL OF BIOTECHNOLOGY
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
- (2010) Anna Maria Calcagno et al. JNCI-Journal of the National Cancer Institute
- Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth
- (2010) M Wang et al. ONCOGENE
- Dasatinib synergizes with doxorubicin to block growth, migration and invasion of breast cancer cells
- (2009) C S Pichot et al. BRITISH JOURNAL OF CANCER
- WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
- (2009) Isabelle Bisson et al. CELL RESEARCH
- Role of Isoprenylcysteine Carboxylmethyltransferase-catalyzed Methylation in Rho Function and Migration
- (2009) Ian Cushman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
- (2009) Robert H Kutner et al. Nature Protocols
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
- (2008) S. W. Chan et al. CANCER RESEARCH
- A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells
- (2008) Mei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started